[vc_row full_width=”stretch_row” css=”.vc_custom_1531732107238{background-color: #fcc118 !important;}”][vc_column]

[/vc_column][/vc_row][vc_row css=”.vc_custom_1531730959461{border-bottom-width: 1px !important;background-color: #f9fafb !important;border-bottom-color: #eef3f7 !important;border-bottom-style: solid !important;}”][vc_column css=”.vc_custom_1531891416301{margin-bottom: 0px !important;}”][bsfp-cryptocurrency style=”widget-6″ align=”auto” columns=”2″ scheme=”light” coins=”top-x-coins” coins-count=”8″ coins-selected=”” currency=”USD” title=”Cryptocurrencies” show_title=”0″ icon=”” heading_color=”” heading_style=”default” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ css=”.vc_custom_1531730265600{margin-bottom: 0px !important;}” custom-css-class=”” custom-id=””][/vc_column][/vc_row]

Infographic: Highlights of Tilray’s Q3 2023 financial results

0

Cannabis company Tilray (NASDAQ: TLRY) has announced financial results for the third quarter of 2023, reporting a net loss and a 4% decrease in revenues.

The company reported a net loss of $1.20 billion or $1.90 per share for the three months ended February 2023, compared to a profit of $52.5 million or $0.09 per share in the prior-year period. Adjusted cannabis gross profit Increased by 23% year-over-year to around $22.2 million.

The bottom line was negatively impacted by a 4% decline in revenues to $145.6 million. At $14.0 million, adjusted EBITDA was up 39%.

Prior Performance

Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More